Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
XPO1 Inhibition Enhances Platinum Sensitivity in GCB-DLBCL
2026-05-22
This study demonstrates that inhibition of XPO1, using agents such as Selinexor, significantly enhances the cytotoxic effects of platinum-based chemotherapy in germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) cells. The findings highlight a mechanistic synergy that may inform future salvage therapy strategies in refractory DLBCL.
-
Acetoacetic Acid Sodium Salt: Gold Standard for Energy Metab
2026-05-22
Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is a rigorously characterized ketone body metabolite essential for energy metabolism research. Its purity, solubility, and validated performance make it a benchmark reagent for investigating fatty acid catabolism, diabetes metabolic imbalance, and ketoacidosis.
-
Acetylcholine Chloride: Precision Tools for Gut-Brain Cholin
2026-05-21
Acetylcholine Chloride from APExBIO empowers translational neuroscience teams to dissect gut-brain cholinergic signaling with high reproducibility. This article bridges recent breakthroughs in antiseizure research with actionable protocols and troubleshooting insights, ensuring robust experimental outcomes in autonomic and central nervous system studies.
-
Nutlin-3a: MDM2 Inhibitor Workflow Innovations for Cancer Re
2026-05-21
Nutlin-3a, a benchmark MDM2 inhibitor, enables precise p53 pathway activation and apoptosis induction in cancer research models. This article delivers actionable workflow enhancements, protocol parameters, and troubleshooting strategies to maximize reproducibility and biological insight.
-
Applied Workflows with Angiotensin 1/2 (2-7) Peptide in RAS
2026-05-20
Angiotensin 1/2 (2-7) peptide stands out for its unmatched purity, robust solubility, and specificity in modeling renin-angiotensin signaling. This article dissects practical workflows, advanced applications, and troubleshooting strategies for maximizing experimental insight in cardiovascular and viral pathogenesis studies.
-
Nystatin (Fungicidin): Reliable Antifungal Solutions for Res
2026-05-20
This article addresses key laboratory challenges encountered in antifungal research and cell-based assays, focusing on the practical deployment of Nystatin (Fungicidin), SKU B1993. Drawing on quantitative benchmarks and evidence-backed workflows, it demonstrates how this APExBIO reagent supports reproducible, sensitive, and safe experimental outcomes for biomedical researchers.
-
Brain-to-Spinal Circuits Regulating Mechanical Allodynia Lat
2026-05-19
Huo et al. (2023) reveal a descending neural pathway—from lateral parabrachial Oprm1+ neurons via hypothalamic dynorphinergic cells to the spinal cord—that critically regulates the laterality and persistence of mechanical allodynia in mice. This work advances understanding of how brain circuits modulate pain hypersensitivity and offers new frameworks for dissecting opioid receptor function in pain research.
-
WM-8014: KAT6A Inhibitor for Precision Cancer Biology Resear
2026-05-19
WM-8014 enables selective, reversible inhibition of KAT6A/B, transforming workflows in oncogene-induced senescence studies. Its robust, non-cytotoxic profile and nanomolar potency set a new standard for dissecting cell cycle arrest and epigenetic dependencies.
-
Applied Workflows with Angiotensin 1/2 (2-7) Peptide in Rese
2026-05-18
Angiotensin 1/2 (2-7) peptide enables precise modeling of the renin-angiotensin system, driving advances in blood pressure regulation and viral pathogenesis research. This article delivers actionable workflow enhancements, troubleshooting strategies, and protocol parameters that maximize experimental reproducibility and translational value.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-05-18
This study reveals that naturally occurring angiotensin peptides, including N-terminally truncated forms such as Angiotensin III, significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor. These findings expand the understanding of peptide-mediated modulation of viral entry and suggest new avenues for investigating the intersection between cardiovascular peptide signaling and viral infection.
-
Sodium Ascorbate: Mechanisms and Benchmarks in Cancer Resear
2026-05-17
Sodium Ascorbate, a mineral salt of ascorbic acid, is a highly bioavailable agent that induces intracellular ROS and necrotic tumor cell death, particularly in glioblastoma models. Evidence shows significant inhibition of tumor proliferation without hematological toxicity. This dossier outlines precise parameters, mechanistic details, and practical workflow guidance for translational oncology.
-
AM251: Precision Protocols for CB1 Receptor Antagonist Resea
2026-05-16
AM251 is a nanomolar-potency CB1 receptor antagonist that enables targeted dissection of endocannabinoid pathways, metabolic regulation, and cell signaling. This article delivers actionable workflows and troubleshooting strategies, bridging advanced cannabinoid receptor research with translational assay development.
-
ω-Agatoxin IVA TFA: Precision Tools for Synaptic Research
2026-05-15
ω-Agatoxin IVA TFA from APExBIO enables precise dissection of P/Q-type calcium channel contributions in neuronal signaling and epilepsy models. This article delivers practical protocols, troubleshooting strategies, and comparative insights to help you leverage this reagent for advanced synaptic and neuroprotection studies.
-
Dronedarone (Multaq): Applied Workflows in Atrial Fibrillati
2026-05-15
Harness the multi-ion channel activity and CYP inhibition profile of Dronedarone (Multaq) to advance atrial fibrillation and flutter research. This guide delivers stepwise protocol enhancements, troubleshooting strategies, and integrates benchmark evidence for reproducible experimental success.
-
Technical Use of Angiotensin I/II (1-5) in RAS Assays
2026-05-14
Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment used to model the renin-angiotensin system (RAS) in hypertension and renal studies where precise control of blood pressure regulation and aldosterone stimulation is required. It is not suitable for workflows outside cardiovascular and renal physiology due to its solubility profile and defined mechanistic action.